Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Hubbard

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Advances in Therapy|April 8, 2025
The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and ObesityAlan Kaplan, Heath Heatley, John Townend, et al.
International Journal of Epidemiology|October 4, 2007
The impact of airborne dust on respiratory health in children living in the Aral Sea regionPolly Bennion, Richard Hubbard, Sarah O'Hara, et al.
Pharmacoepidemiology and Drug Safety|February 26, 2022
Validation of diagnostic coding for interstitial lung diseases in an electronic health record system in Hong KongYisha Ye, Richard Hubbard, Gloria Hoi-Yee Li, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2003
Wheezing, allergy, and parasite infection in children in urban and rural EthiopiaDamtew Dagoye, Zegaye Bekele, Kifle Woldemichael, et al.
Chest|January 14, 2023
The Impact of COVID-19 on Lung Cancer Incidence in England: Analysis of the National Lung Cancer Audit 2019 and 2020 Rapid Cancer Registration DatasetsSavannah Gysling, Helen Morgan, Onosi Sylvia Ifesemen, et al.
Rheumatology (Oxford, England)|October 26, 2021
COVID-19 infection, admission and death among people with rare autoimmune rheumatic disease in England: results from the RECORDER projectMegan Rutter, Peter C Lanyon, Matthew J Grainge, et al.
Rheumatology (Oxford, England)|April 5, 2023
COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER ProjectMegan Rutter, Peter C Lanyon, Matthew J Grainge, et al.
The Lancet Regional Health. Western Pacific|February 15, 2024
Prevalence, incidence, and survival analysis of interstitial lung diseases in Hong Kong: a 16-year population-based cohort studyYisha Ye, Chor-Wing Sing, Richard Hubbard, et al.
Journal of the National Medical Association|October 7, 2010
Addressing obesity and diabetes among African American men: examination of a community-based model of preventionHenrie Treadwell, Kisha Holden, Richard Hubbard, et al.
ERJ Open Research|March 5, 2025
Incidence and survival of interstitial lung diseases in the UK in 2010-2019Francesca Gonnelli, Neva Eleangovan, Ursie Smith, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Advances in Therapy|April 8, 2025
The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and ObesityAlan Kaplan, Heath Heatley, John Townend, et al.
International Journal of Epidemiology|October 4, 2007
The impact of airborne dust on respiratory health in children living in the Aral Sea regionPolly Bennion, Richard Hubbard, Sarah O'Hara, et al.
Pharmacoepidemiology and Drug Safety|February 26, 2022
Validation of diagnostic coding for interstitial lung diseases in an electronic health record system in Hong KongYisha Ye, Richard Hubbard, Gloria Hoi-Yee Li, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2003
Wheezing, allergy, and parasite infection in children in urban and rural EthiopiaDamtew Dagoye, Zegaye Bekele, Kifle Woldemichael, et al.
Chest|January 14, 2023
The Impact of COVID-19 on Lung Cancer Incidence in England: Analysis of the National Lung Cancer Audit 2019 and 2020 Rapid Cancer Registration DatasetsSavannah Gysling, Helen Morgan, Onosi Sylvia Ifesemen, et al.
Rheumatology (Oxford, England)|October 26, 2021
COVID-19 infection, admission and death among people with rare autoimmune rheumatic disease in England: results from the RECORDER projectMegan Rutter, Peter C Lanyon, Matthew J Grainge, et al.
Rheumatology (Oxford, England)|April 5, 2023
COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER ProjectMegan Rutter, Peter C Lanyon, Matthew J Grainge, et al.
The Lancet Regional Health. Western Pacific|February 15, 2024
Prevalence, incidence, and survival analysis of interstitial lung diseases in Hong Kong: a 16-year population-based cohort studyYisha Ye, Chor-Wing Sing, Richard Hubbard, et al.
Journal of the National Medical Association|October 7, 2010
Addressing obesity and diabetes among African American men: examination of a community-based model of preventionHenrie Treadwell, Kisha Holden, Richard Hubbard, et al.
ERJ Open Research|March 5, 2025
Incidence and survival of interstitial lung diseases in the UK in 2010-2019Francesca Gonnelli, Neva Eleangovan, Ursie Smith, et al.
Pageof 12